We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$332M
AUM Growth
+$142M
Cap. Flow
+$119M
Cap. Flow %
35.99%
Top 10 Hldgs %
4.82%
Holding
913
New
440
Increased
113
Reduced
66
Closed
294

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$1.7M
2
SLB icon
SLB Ltd
SLB
+$1.68M
3
DAY
Dayforce
DAY
+$1.59M
4
IDA icon
Idacorp
IDA
+$1.58M
5
V icon
Visa
V
+$1.49M

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$968K
2
ADM icon
Archer Daniels Midland
ADM
+$967K
3
HCA icon
HCA Healthcare
HCA
+$966K
4
ABT icon
Abbott
ABT
+$966K
5
SPGI icon
S&P Global
SPGI
+$965K

Sector Composition

Rank Sector Weight
1 Technology 18.79%
2 Healthcare 14.71%
3 Industrials 14.47%
4 Consumer Discretionary 11.29%
5 Financials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GH icon
226
Guardant Health
GH
$19.2B
$543K 0.16%
20,073
+5,698
+40% +$149K
CDNA icon
227
CareDx
CDNA
$1.85B
$542K 0.16%
+45,167
New +$370K
USNA icon
228
Usana Health Sciences
USNA
$430M
$542K 0.16%
+10,111
New +$511K
DHT icon
229
DHT Holdings
DHT
$3.01B
$541K 0.16%
55,127
-6,673
-11% -$68.7K
PRLB icon
230
Protolabs
PRLB
$1.79B
$540K 0.16%
+13,864
New +$449K
USB icon
231
US Bancorp
USB
$99.6B
$538K 0.16%
+12,428
New +$454K
MRUS
232
DELISTED
Merus
MRUS
$537K 0.16%
+19,524
New +$456K
PTC icon
233
PTC
PTC
$14.8B
$536K 0.16%
+3,066
New +$470K
CNI icon
234
Canadian National Railway
CNI
$77.9B
$535K 0.16%
+4,261
New +$483K
DSGX icon
235
Descartes Systems
DSGX
$6.46B
$534K 0.16%
+6,356
New +$495K
CW icon
236
Curtiss-Wright
CW
$26.8B
$531K 0.16%
2,385
+27
+1% +$5.65K
ADT icon
237
ADT
ADT
$5.33B
$531K 0.16%
77,816
+56,592
+267% +$353K
KD icon
238
Kyndryl
KD
$2.95B
$528K 0.16%
+25,389
New +$434K
FCFS icon
239
FirstCash
FCFS
$9.02B
$524K 0.16%
+4,830
New +$523K
AGIO icon
240
Agios Pharmaceuticals
AGIO
$2.16B
$520K 0.16%
+23,338
New +$523K
PFE icon
241
Pfizer
PFE
$143B
$519K 0.16%
+18,016
New +$545K
ABR icon
242
Arbor Realty Trust
ABR
$977M
$514K 0.16%
+33,879
New +$466K
SITM icon
243
SiTime
SITM
$14.6B
$512K 0.15%
4,196
+2,280
+119% +$258K
TK icon
244
Teekay
TK
$988M
$512K 0.15%
71,622
+42,285
+144% +$292K
CHH icon
245
Choice Hotels
CHH
$5.22B
$512K 0.15%
+4,518
New +$516K
ELF icon
246
e.l.f. Beauty
ELF
$4.91B
$510K 0.15%
+3,535
New +$408K
JEF icon
247
Jefferies Financial Group
JEF
$13.1B
$507K 0.15%
+12,542
New +$444K
BNS icon
248
Scotiabank
BNS
$108B
$502K 0.15%
+10,314
New +$454K
BRBR icon
249
BellRing Brands
BRBR
$1.6B
$502K 0.15%
+9,058
New +$437K
SHOO icon
250
Steven Madden
SHOO
$3.21B
$500K 0.15%
+11,898
New +$432K
8 9
10
11 12

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q4 2023 Portfolio in Review

As of Q4 2023, Nebula Research & Development held 913 positions worth $332M, up 75% from $190M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

Nebula Research & Development deployed $119M of net new capital in Q4 2023, opening 440 new positions and adding to 113 existing holdings. Its largest new stake was Humana: 3,439 shares worth $1.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Hanesbrands, an estimated $775K trimmed.

  • Nebula Research & Development's largest Q4 2023 buy was Humana: 3,439 shares worth $1.57M.
  • Nebula Research & Development added most to AppFolio in Q4 2023, an estimated $1.43M increase.
  • Nebula Research & Development's biggest Q4 2023 reduction was Hanesbrands, cutting an estimated $775K.
  • Nebula Research & Development fully exited Intuit in Q4 2023, selling an estimated $968K.
  • Nebula Research & Development's ten largest holdings make up 4.8% of its $332M portfolio in Q4 2023.
  • Nebula Research & Development opened 440 new positions and closed 294 in Q4 2023.
  • Nebula Research & Development's portfolio value rose 75% quarter-over-quarter to $332M.

Based on Nebula Research & Development's 13F filing for Q4 2023, filed 14 Feb 2024.